Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* NB Public Equity K/S (Last) (First) (Middle) OESTERGADE 5, 3RD FLOOR, DK-1100 (Street) COPENHAGEN K, DENMARK G7 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 01/30/2009	3. Issuer Name and Ticker or Trading Symbol QLT INC/BC [ QLTI ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares, no par value	6,513,579	D(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* NB Public Equity K/S (Last) (First) (Middle) OESTERGADE 5, 3RD FLOOR, DK-1100 (Street) COPENHAGEN K, DENMARK G7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* NB Public Equity Komplementar ApS (Last) (First) (Middle) OESTERGADE 5, 3RD FLOOR, DK-1100 (Street) COPENHAGEN K, DENMARK G7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Madsen Cora (Last) (First) (Middle) OESTERGADE 5, 3RD FLOOR, DK-1100 (Street) COPENHAGEN K, DENMARK G7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Hansen Christian (Last) (First) (Middle) OESTERGADE 5, 3RD FLOOR, DK-1100 (Street) COPENHAGEN K, DENMARK G7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Schonharting Florian (Last) (First) (Middle) OESTERGADE 5, 3RD FLOOR, DK-1100 (Street) COPENHAGEN K, DENMARK G7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. These shares are owned directly by NB Public Equity K/S (the "Fund"). They are owned indirectly by NB Public Equity Komplementar ApS (the "General Partner"), which is the general partner of the Fund and may be deemed to be the beneficial owner of the securities held by the Fund by reason of its managment of the Fund. The shares are also indirectly owned by Cora Madsen, who has the legal power to vote or dispose of the shares beneficially owned by the Fund as Director of the General Partner, and Christian Hansen and Florian Schonharting, who are directors of Nordic Biotech Advisors ApS, which owns 100% of the General Partner. Each of the foregoing indirect owners of the securities hereby disclaims any beneficial ownership of all such securities for purposes of Section 16 of the Securities Exchange Act of 1934, except to the extent of their pecuniary interest therein.

Remarks:

	/s/ James E. Dawson, as attorney in fact	02/06/2009
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.